$TCBIONeutralLow

Texas Capital Bancshares, Inc. (NASDAQ:TCBIO) Sees Significant Drop in Short Interest

Texas Capital Bancshares (NASDAQ:TCBIO) reported a sharp May decline in short interest. According to the data cited, short interest fell to 13,321 shares as of May 15 from 52,386 on April 30 (down 74.6%); days to cover is 0.8 based on average daily volume of 17,458. The stock was down 0.4% to $21.18 mid-day. The company also declared a $0.3594 quarterly dividend payable June 15 to holders of record June 1.

Low
Neutral
Ahead of the June 1 record date and June 15 payment; short-interest update as of May 15.
Slightly supportive (less bearish positioning), but not a catalyst by itself.

Lower short interest and a near-term dividend can reduce near-term downside pressure, but the piece is mostly positioning/flow data.

Article reports a 74.6% drop in TCBIO short interest and notes the stock is down 0.4% midday, alongside a dividend date.

Mildly positive bias for the next few sessions, with limited follow-through unless price/volume confirms a squeeze or trend reversal.

Background

Short interest fell to 13,321 shares as of May 15 from 52,386 at April 30; the article also reiterates a quarterly dividend ($0.3594) with record June 1 and payment June 15.

Why it matters

For traders, the actionable elements are (1) potential reduction in bearish pressure from lower short interest and (2) calendar effects around the record/payment dates; there is no mention of earnings, credit events, or regulatory actions.

Market relevance

Positioning data (short interest) plus a dividend calendar can influence short-term trading, but the article lacks a fundamental catalyst.

Market effects

Bank stocks can see sentiment swings from positioning data; however, this is single-name flow rather than a sector catalyst.

Limited—Texas Capital is Dallas-based, but the article provides no regional macro trigger.

Low—no cross-border or macro shock described.

Alternative perspectives

A sharp short-interest drop can reflect shorts exiting for reasons unrelated to fundamentals (e.g., liquidity/hedging changes), so price may not sustain.

The article doesn’t provide borrow rates, options positioning, or whether the stock’s move is driven by broader bank/credit news—those could dominate the setup.

Key entities

  • Texas Capital Bancshares, Inc.

    Subject of the article; short interest dropped sharply and a quarterly dividend schedule is provided.

Related articles

$TCBIOMed

Texas Capital Bancshares stock hits 52-week high at 20.95 USD

Texas Capital Bancshares (TCBIO) stock recently reached a 52-week high of $20.95, reflecting strong investor confidence and a 11.12% total return over the past year. The company boasts a market capitalization of $4.34 billion, a P/E ratio of 13.23, and an attractive dividend yield of 6.86%, with InvestingPro analysis suggesting it may still be undervalued. This performance comes despite broader concerns within the banking sector regarding private credit exposure and NDFI loans, highlighted by Raymond James.

$TCBIOLow

Trustmark names next COO, CFO

Trustmark has appointed its current CFO, Thomas Owens, as chief operating officer, effective May 1. Joseph Bond, formerly corporate treasurer at Texas Capital Bancshares, will replace Owens as CFO. Owens has been with Trustmark for 13 years and became CFO in 2021.

$TCBIOLow

Texas Capital Bancshares Board Director Buys 40K Shares for $888K

Robert W. Stallings, a director at Texas Capital Bancshares, recently purchased 40,000 depositary shares for approximately $888,000. These shares, known as TCBIO, represent ownership interests in Series B Preferred shares and offer dividends but no voting power, unlike the common stock TCBI. The transaction occurred amidst a positive stock performance for the company in 2026, though its financials have seen recent fluctuations and operational focus is limited to Texas.

$NVDAMed

Markets have worst day since October as tech stocks lead the way down, traders lose hope of rate cut

The S&P 500 fell 2.6% on Friday, its biggest one-day drop since Oct. 10, with the Nasdaq down 4.2% and the Dow down 1.4%. Tech led losses: Nvidia -6.2%, Broadcom -7.9%, Micron -13.3%, and Meta -5.5% after a report it may seek a new stock offering. Bond yields rose after the Labor Department said May jobs increased by 172,000, reducing expectations for a Fed rate cut.

$RIVNMed

If You Buy Rivian Right Now, Could It Make You a Millionaire?

Rivian says it has expanded capacity at its Georgia plant to 300,000 vehicles and received an additional $1 billion in cash from Volkswagen. The company also began delivering the first batch of its mass-market R2 trucks to employees. Rivian aims to scale production to reach sustainable profitability, with an expected first advance on a $4.5 billion U.S. loan in early 2027.